GlaxoSmithKline sold an improperly made antidepressant and tainted skin ointment, regulators said.
A company subsidiary agreed Tuesday to plead guilty to allegations that the plant churned out medications that were mislabeled, mixed up in the wrong packaging, and even defective -- made either too weak or too strong.
The defects affected such popular prescription drugs as the antidepressant Paxil and the ointment Bactroban, used to treat skin infections.
~
No comments:
Post a Comment